Skip to main content
. Author manuscript; available in PMC: 2022 May 12.
Published in final edited form as: Lancet Microbe. 2022 Jan 19;3(5):e392–e398. doi: 10.1016/S2666-5247(21)00250-0

Figure 1: Study selection and primary findings.

Figure 1:

ART=antiretroviral therapy. INSTI=integrase strand transfer inhibitor. PrEP=pre-exposure prophylaxis.

*656 excluded studies comprised: studies of in-vitro susceptibility, biochemistry, mathematical modelling, and sequencing methods that lacked a description of the population from which virus sequences were obtained; studies devoted to HIV-1 quasispecies but not to HIV-1 drug resistance; and studies published in the National Center for Biotechnology Information Sequence Read Archive but not in GenBank.